CRIZANLIZUMAB

Clinical Indication

Preventing sickle cell crises in sickle cell disease

Comments

In line with NICE TA743

Date of classification

December 2021

Review date

December 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.